⌘K

Login Start Free

Home/Filings/4/0001136261-21-000004

4//SEC Filing

Dunn Judith 4

Accession 0001136261-21-000004

CIK 0001017491other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:30 PM ET

Size

5.4 KB

Accession

0001136261-21-000004

Insider Transaction Report

Form 4

Period: 2021-01-06

SEELOS THERAPEUTICS, INC.SEEL

Director

Transactions

Award
Stock Option (right to buy)
2021-01-06+16,000→ 16,000 total
Exercise: $1.35Exp: 2031-01-06→ Common Stock (16,000 underlying)

Footnotes (1)

[F1]1/12th of the shares subject to the option shall vest on February 6, 2021, and 1/12th of the shares subject to the option shall vest monthly thereafter.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

SEELOS THERAPEUTICS, INC.

CIK 0001017491

Entity typeother

Related Parties

1

filerCIK 0001811904

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 4:30 PM ET
Size: 5.4 KB

View on SEC.gov